Application no. and date | 17867252.3 (espacenet) (Federated) (European Patent Register), 20171101 | Patent/reg. no. and date | DK/EP 3535397, 20220105 | Publication date | 20190911 | Priority no. and date | US 201662415752 P, 20161101 | EP pub. no. and date |
EP 3535397 20190911 | Effective date | | Applicant/owner | Arrowhead Pharmaceuticals, Inc., 177 E. Colorado Boulevard, Suite 700
Pasadena, CA 91105, US | Applicant ref. no. | BBS181084EPDK | Inventor | ALMEIDA, Aaron, 490 Togstad Glenn
Madison, WI 53711, US, LI, Zhen, Arrowhead Pharmaceuticals Inc. 502 S. Rosa Road
Madison, WI 53719, US, PEI, Tao, Arrowhead Pharmaceuticals Inc. 502 S. Rosa Road
Madison, WI 53719, US, NICHOLAS, Anthony, Arrowhead Pharmaceuticals Inc. 502 S. Rosa Road
Madison, WI 53719, US, BUSH, Erik, W, Arrowhead Pharmaceuticals Inc. 502 S. Rosa Road
Madison, WI 53719, US, GLEBOCKA, Angieszka, Arrowhead Pharmaceuticals Inc. 502 S. Rosa Road
Madison, WI 53719, US, CARLSON, Jeffrey, Arrowhead Pharmaceuticals Inc. 502 S. Rosa Road
Madison, WI 53719, US, FOWLER-WATTERS, Matthew, Arrowhead Pharmaceuticals Inc. 502 S. Rosa Road
Madison, WI 53719, US | Representative | Novagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017
F-92665 Asnières-sur-Seine cedex, FR | Opponent | | IPC Class | A61K 31/713 (2006.01) , A61K 47/60 (2017.01) , A61K 47/64 (2017.01) , A61P 35/00 (2006.01) , C07K 7/02 (2006.01) , C07K 7/06 (2006.01) , C12N 15/113 (2010.01) , A61K 38/00 (2006.01) , C07K 19/00 (2006.01) | Title | ALFA-V-BETA-6-INTEGRIN-LIGANDER OG ANVENDELSER DERAF | Int. application no. | US2017059550 | Int. publication no. | WO2018085415 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|